Race investor briefing & updated presentation
Race Oncology Limited (ASX: RAC) (Race) is pleased to release an updatedinvestor presentation and invite…
Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.
ASX Announcements
Share Price
Latest News
Race Initiates Heart Safety Preclinical Study for Bisantrene
In >40 clinical trials, Bisantrene has been shown to have low cardiotoxicityThis study will assess…
Race appoints Dr David Fuller Chief Medical Officer
Former Senior Vice President of Clinical Development at Syneos HealthDr Fuller brings over 30 years’…
City of Hope Professor Jianjun Chen joins Race’s Scientific Advisory Board
Professor Jianjun Chen of the City of Hope Hospital appointed to Race’s Scientific Advisory BoardProf…
Second independent study shows Bisantrene inhibits FTO
Bisantrene shown by the University of Chicago to target the Fat Mass and Obesity associated…
Race Investor Update March 2021
Race updates its Three Pillar Strategy, detailing intended programs and activitiesThe update confirms progress on…
